The effect of thyroid hormones in psoriasis vulgaris

Indian Journal of Dermatology, Venereology and Leprology

Volumn 70, Issue 6, 2004, Pages 354-356

  Arican, Ozer ^a,d   Bilgic, Kaan ^b   Koc, Kadriye ^c  

^a KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

^b Boyabat Hospital   (Turkey)

^c HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^d NONE   (Turkey)

Author keywords

Psoriasis area severity index (PASI); T3; T4; TSH

Indexed keywords

THYROID HORMONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PSORIASIS VULGARIS; STATISTICAL ANALYSIS; THYROID HORMONE BLOOD LEVEL;

EID: 14844311332     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. th Ed. New York: McGraw-Hill; 1999. p. 495-521.
2. Tagami H. Triggering factors. Clin Derm 1997;15:677-85.
3. Humphreys MS, Waddell JL. Lithium, psoriasis, abnormal glucose tolerance and thyroid dysfunction. Br J Psychiatry 1988;152:437-8.
4. Hoath SB, Lakshmanan J, Scott SM, Fisher DA. Effect of thyroid hormones on epidermal growth factor concentration in neonatal mouse skin. Endocrinology 1983;112:308-14.
5. Safer JD, Fraser LM, Ray S, Holick MF. Topical triiodothyronine stimulates epidermal proliferation, dermal thickening, and hair growth in mice and rats. Thyroid 2001;11:717-24.
6. Safer JD, Crawford TM, Fraser LM, Hoa M, Ray S, Chen TC, et al. Thyroid hormone action on skin: Diverging effects of topical versus intraperitoneal administration. Thyroid 2003;13:159-65.
7. Elias AN, Dangaran K, Barr J, Rohan K, Goodman MM. A controlled trial of topical propylthiouracil in the treatment of patients with psoriasis. J Am Acad Dermatol 1994;31:455-8.
8. Elias AR, Barr RJ. Low dose oral propylthiouracil in the treatment of plaque psoriasis. Int J Dermatol 1995;34:519-20.
9. Elias AN, Goodman MM, Liem WH, Barr J. Propylthiouracil in psoriasis: Result of an open trial. J Am Acad Dermatol 1993;29:78-81.
10. Chowdhury MM, Marks R. Oral propylthiouracil for the treatment of resistant plaque psoriasis. J Dermatol Treat 2001;12:81-5.
11. Elias AN, Goodman MM, Rohan MK, Alpern K, Barr RJ. Methimazole in psoriasis: Results of an open trial. Dermatology 1993;187:26-9.
12. Abe M, Ohnishi K, Hasegawa M, Aoyama K, Tamura A, Kan C, et al. The antipsoriatic effect of thiamazole is not accompanied either by significant changes in blood lymphocyte subsets nor by serum concentration of TNF-alpha. Eur J Dermatol 2002;12:335-9.
13. Ribeiro RC, Apriletti JW, West BL, Wagner RL, Fletterick RJ, Schaufele F, et al. The molecular biology of thyroid hormone action. Ann N Y Acad Sci 1995;758:366-89.
14. 3 binding to hepatic nuclear receptor. Biochem Cell Biol 1990;68:616-21.
15. Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, Fletterick RJ. A structural role for hormone in the thyroid hormone receptor. Nature 1995;378:690-7.
16. Torma H, Rollman O, Vahlquist A. Detection of mRNA transcripts for retinoic acid, vitamin D3, and thyroid hormone (c-erb-A) nuclear receptors in human skin using reverse transcription and polymerase chain reaction. Acta Derm Venereol 1993;73:102-7.
17. Hoath SB, Lakshmanan J, Fisher DA. Epidermal growth factor binding to neonatal mouse skin explants and membrane preparations - effect of triiodothyronine. Pediatr Res 1985;19:277-81.